<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE305nnn/GSE305395/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305395</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>PGC-1alpha pathway dysregulation disrupts myofiber specification in a mouse model of SBMA [AR113Q RNA-Seq]</name><description>Skeletal muscle pathology is a critical but poorly understood contributor to neuromuscular degeneration in spinal and bulbar muscular atrophy (SBMA), a CAG/polyglutamine (polyQ) expansion disorder caused by mutation in the androgen receptor (AR). Using a gene-targeted SBMA mouse model, we applied single-nucleus RNA sequencing to identify a previously unrecognized, disease-specific population of skeletal muscle myonuclei that replace normal myonuclear subtypes. This transition was driven by dysregulation of the PGC-1α pathway, a central regulator of myofiber specification and metabolic identity. PGC-1α dysfunction in SBMA muscle was age-, hormone-, and polyQ length–dependent and was partially rescued by subcutaneous delivery of AR-targeted antisense oligonucleotides. Integrated ChIP-seq and RNA-seq analyses revealed that aberrant PGC-1α activity promoted the expression of a distinct set of myofiber specification genes while downregulating those defining healthy Type IIb and Type IIx myonuclei. We propose a model in which this dysfunction arose downstream of polyQ-mediated sequestration of PGC-1α cofactors MEF2, CREB, and CBP, leading to transcriptional reprogramming and cellular dysfunction. These findings implicate PGC-1α dysregulation as a key event linking AR polyQ expansion to skeletal muscle degeneration and suggest a shared mechanism for polyQ-mediated muscle pathology across related neurodegenerative diseases.</description><dates><publication>2026/04/15</publication></dates><accession>GSE305395</accession><cross_references><GSM>GSM9170977</GSM><GSM>GSM9170955</GSM><GSM>GSM9170976</GSM><GSM>GSM9170954</GSM><GSM>GSM9170953</GSM><GSM>GSM9170975</GSM><GSM>GSM9170974</GSM><GSM>GSM9170952</GSM><GSM>GSM9170951</GSM><GSM>GSM9170973</GSM><GSM>GSM9170972</GSM><GSM>GSM9170971</GSM><GSM>GSM9170970</GSM><GSM>GSM9170959</GSM><GSM>GSM9170958</GSM><GSM>GSM9170957</GSM><GSM>GSM9170956</GSM><GSM>GSM9170966</GSM><GSM>GSM9170965</GSM><GSM>GSM9170964</GSM><GSM>GSM9170963</GSM><GSM>GSM9170962</GSM><GSM>GSM9170961</GSM><GSM>GSM9170960</GSM><GSM>GSM9170969</GSM><GSM>GSM9170968</GSM><GSM>GSM9170967</GSM><GPL>24247</GPL><GPL>34328</GPL><GSE>305395</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>